BRITISH researchers say they have found that a drug, originally developed to treat leukaemia, can halt and even reverse the debilitating effects of multiple sclerosis (MS).
In trials, alemtuzumab reduced the number of attacks in sufferers and also helped them recover lost functions, apparently allowing damaged brain tissue to repair so that individuals were less disabled than at the start of the study.
More at
News.com.au
You need to be a member of DoctorsHangout.com to add comments!
Join DoctorsHangout.com